This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
HBB / Hemoglobin subunit beta · Western blot design guide
Design a Western Blot for HBB
Real validated HBB Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HBB WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
HBB Western Blot Experimental Design Guide
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | ~16 kDa | |
| Observed band | ~13 kDa | |
| Gel | 10% (catalog A00147-1) | |
| Positive control | Bone marrow (IHC candidate; verify WB) +2 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
Important caveats
Reasons your observed band may differ from the expected size.
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Band identity controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
Section 1
Real Curated HBB Western Blot Protocols
The A00147-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, rat heart, rat lung (catalog A00147-1) |
| Gel % | 10% (catalog A00147-1) |
| Load | 30 ug; reducing conditions (catalog A00147-1) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A00147-1) |
| Membrane | nitrocellulose membrane (catalog A00147-1) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A00147-1) |
| Primary antibody | A00147-1 · 1:1000 (catalog A00147-1) |
| Primary incubation | overnight at 4°C (catalog A00147-1) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A00147-1) |
| Secondary incubation | 1.5 hour at RT (catalog A00147-1) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A00147-1) |
| Detection | ECL (catalog A00147-1) |
Section 2
What Is the Expected HBB Western Blot Band Size?
HBB is predicted at 16 kDa, while antibody QC observes ~13 kDa; the cause of the difference is not established.
| Band at ~13 kDa | Empirical HBB band reported in antibody QC; confirm identity with appropriate controls |
| Band near 16 kDa | Near HBB's predicted mass; identity requires confirmation |
| Closely spaced bands near the main band | Could include modified HBB, but the listed modifications do not establish a visible doublet |
| No separate Hb A1c band | Val2 glucose glycation does not necessarily resolve as a distinct band |
💡Expected HBB appearanceHBB has a predicted mass of 16 kDa, while antibody QC reports a band at ~13 kDa; the cause of the difference is unestablished, so confirm band identity with appropriate controls.
| Predicted HBB mass | 16 kDa by sequence; antibody QC reports an apparent band at ~13 kDa |
| Val2 N-linked glucose glycation in Hb A1c | Adds glucose, but a visible size shift is not established |
| Lys9 N-linked glucose glycation | Adds glucose, but a resolvable band change is not established |
| Lys18 N-linked glucose glycation | Adds glucose, but a resolvable band change is not established |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | Modified HBB is possible, but glycation sites alone do not establish the shift | Confirm HBB identity and test the suspected modification separately |
| Band lower than expected | The reported ~13 kDa band is below the 16 kDa predicted mass for an unknown reason | Compare with the antibody QC result and confirm identity using an HBB control |
| Broad smear instead of sharp band | The supplied glycation sites do not establish a smear | Check loading and sample quality, then verify HBB identity across the smear |
| Multiple bands | Listed modifications may produce HBB species, but distinct migration is unproven | Use an HBB identity control and test modifications if implicated |
| Weak or no signal | HBB abundance or antibody detection may be insufficient in the sample | Run an HBB-positive control and check loading and antibody detection |
Experiment evidence
Western blot images showing HBB band
A00147-1 · HBB
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for HBB Western blot
🧪HPA-IHC candidate guidance (verify in WB): For positive controls for HBB in Western blot, you can use bone marrow tissue.
Positive control: Bone marrow (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: HPA rates bone marrow as medium and adipose tissue as not detected, so the positive signal may be modest.
HPA tissue expression evidence for HBB
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Higher expression tissues · candidate positive controls from IHC
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Lung | alveolar cells type II | Medium | Protein (IHC) | HPA → |
| Placenta | trophoblastic cells | Medium | Protein (IHC) | HPA → |
Lower expression tissues · IHC evidence, not confirmed WB-negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced HBB Western Blot Tips
Deeper troubleshooting and optimisation questions for HBB, answered from its protein features.
How should HBB band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could HBB isoforms explain multiple bands?
Isoforms · The supplied record lists one isoform and no alternative sequence. It therefore does not support assigning additional bands to HBB isoforms. Verify the identity of each band before including it in HBB analysis.
Which HBB phosphorylation sites should I consider?
PTM · UniProt lists phosphoserine at positions 10 and 45 and phosphothreonine at positions 13, 51, and 88. These sites identify possible modified forms, but their presence alone does not predict a resolved band shift.
At UniProt position 2, Hb A1c has glucose glycation of valine, while Hb A1b has N-pyruvate 2-iminyl-valine. Other listed glycation sites are lysines 9, 18, 67, 121, and alternate site 145. A band position alone cannot distinguish these forms.
Coordinates here follow the 147-residue UniProt canonical sequence, which begins with methionine. The valine listed at UniProt position 2 may be numbered differently in material using a processed-chain convention. Check the numbering convention before comparing site-specific claims.
At UniProt position 2, Hb A1c has glucose glycation of valine, while Hb A1b has N-pyruvate 2-iminyl-valine. Other listed glycation sites are lysines 9, 18, 67, 121, and alternate site 145. A band position alone cannot distinguish these forms.
Coordinates here follow the 147-residue UniProt canonical sequence, which begins with methionine. The valine listed at UniProt position 2 may be numbered differently in material using a processed-chain convention. Check the numbering convention before comparing site-specific claims.
Does this guide establish induction of HBB?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for HBB?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A00147-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should I quantify HBB if several bands appear?
Quantitation · The supplied observed HBB band is about 13 kDa. Quantify that band consistently across samples; include another band in total HBB only after confirming its identity. The listed sites do not show which modified forms, if any, resolve separately.
Why might HBB appear near 13 kDa rather than its predicted 16 kDa?
Interpretation · The supplied observed band is about 13 kDa, while predicted HBB mass is 16 kDa. The listed modifications do not establish the cause of this difference or demonstrate a visible shift. Use the observed position as a reference, and verify band identity before assigning the discrepancy to a modification.
UniProt lists N-acetylvaline at position 2, N6-acetyllysine at positions 60 and 83 and alternate position 145, and S-nitrosocysteine at position 94. Treat these as candidate modifications when investigating an unexpected band; the record does not establish that any produces a visible shift.
Adult hemoglobin A contains two alpha chains and two beta chains. This makes a complex a possibility to investigate, but the oligomer description alone cannot identify a higher Western-blot band. Confirm the band before assigning it to an HBB-containing complex.
UniProt lists N-acetylvaline at position 2, N6-acetyllysine at positions 60 and 83 and alternate position 145, and S-nitrosocysteine at position 94. Treat these as candidate modifications when investigating an unexpected band; the record does not establish that any produces a visible shift.
Adult hemoglobin A contains two alpha chains and two beta chains. This makes a complex a possibility to investigate, but the oligomer description alone cannot identify a higher Western-blot band. Confirm the band before assigning it to an HBB-containing complex.
Boster reagents
HBB Western Blot Antibodies
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Real WB data
Anti-HBB Antibody
Cat # A00147-1
The catalog reports one anti-HBB antibody, A00147-1, with a Western blot image. Its caption reports a band near 13 kDa, versus an expected 16 kDa, in the listed human, rat, and mouse samples; these examples do not establish performance in every tissue.
Which to pick: A00147-1 is the only listed option. Its reported reactivity is human, mouse, and rat, and its WB image uses HeLa cells plus rat and mouse heart and lung lysates. Check the 13 kDa observed band against your expected result.
Source: BosterBio HBB gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.
References
- UniProt Consortium. UniProt entry P68871.
- Human Protein Atlas. HBB tissue expression.
- PMC5625664 — target-verified WB comparison
- PMC11057351 — target-verified WB comparison
- PMC5007518 — target-verified WB comparison